Manatuck Hill Partners, LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 40 filers reported holding CASI PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Manatuck Hill Partners, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$12,000
-33.3%
15,0900.0%0.01%
-16.7%
Q3 2021$18,000
-21.7%
15,0900.0%0.01%
-14.3%
Q2 2021$23,0000.0%15,0900.0%0.01%
-36.4%
Q3 2020$23,000
-39.5%
15,0900.0%0.01%
-50.0%
Q2 2020$38,000
-45.7%
15,0900.0%0.02%
-15.4%
Q3 2018$70,000
-43.5%
15,0900.0%0.03%
-48.0%
Q2 2018$124,000
+359.3%
15,0900.0%0.05%
+284.6%
Q3 2017$27,000
+68.8%
15,0900.0%0.01%
+62.5%
Q2 2017$16,000
-23.8%
15,0900.0%0.01%
-11.1%
Q1 2017$21,000
+23.5%
15,0900.0%0.01%
+28.6%
Q3 2016$17,000
-5.6%
15,0900.0%0.01%
-12.5%
Q2 2016$18,000
+12.5%
15,0900.0%0.01%
+33.3%
Q1 2016$16,0000.0%15,0900.0%0.01%
-14.3%
Q3 2015$16,000
-40.7%
15,0900.0%0.01%
-12.5%
Q2 2015$27,0000.0%15,0900.0%0.01%
+33.3%
Q3 2014$27,00015,0900.01%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
IDG-Accel China Growth Fund III Associates L.P. 7,973,536$23,522,00027.18%
Consonance Capital Management LP 7,576,431$22,350,0002.09%
Wellington Shields & Co., LLC 1,812,769$5,348,0001.92%
Wellington Shields Capital Management, LLC 2,071,765$6,112,0000.82%
Ikarian Capital, LLC 1,268,154$3,741,0000.16%
Sio Capital Management, LLC 203,432$600,0000.12%
Zebra Capital Management LLC 11,182$33,0000.04%
FEDERATED HERMES, INC. 7,000,000$20,650,0000.04%
GSA CAPITAL PARTNERS LLP 52,146$154,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 161,949$478,0000.02%
View complete list of CASI PHARMACEUTICALS INC shareholders